ON PHOTOPHERESIS EFFICIENCY IN ANETODERMIA


Cite item

Full Text

Abstract

Extracorporeal photochemotherapy — photopheresis — was used for the treatment of anetodermia. A pronounced clinical effect (4 sessions every other day) was attained in the treatment of Schwenninger-Buzzi’a anetodermia (developing in the presence of Lewandowsky-Lutz verruciform epidermodysplasia) and Jadassohn ’s anetodermia. Photopheresis induced a trend to normalization of some immunological parameters. This is the first in world literature report about pronounced clinical efficiency and pathogenetic nature of photopheresis in anetodermia.

About the authors

V. A Molochkov

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

заслуженный деятель науки, доктор мед. наук, профессор Отделение дерматовенерологии и дерматоонкологии

O. V Karzanov

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

кандидат мед. наук, старший научный сотрудник Отделение дерматовенерологии и дерматоонкологии

A. A Prokofyev

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

Email: alex-prok3@mail.ru
младший научный сотрудник Отделение дерматовенерологии и дерматоонкологии

Yu. V Molochkova

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

клинический ординатор Отделение дерматовенерологии и дерматоонкологии

References

  1. Thomas J.E., Mehregan D.R., Holland J., Mehregan D.A. Familial anetoderma. Int. J. Dermatol. 2003; 42(1): 75—7.
  2. Kineston D.P., Xia Y., Turiansky G.W. Anetoderma: a case report and review of the literature. Cutis. 2008; 81(6): 501—6.
  3. Sparsa A., Piette J.C., Wechsler B., Amoura Z., Franc S.C. Anetoderma and its prothrombotic abnormalities. J. Am. Acad. Dermatol. 2003; 49(6): 1008—12.
  4. Braun R.P., Borradori L., Chavaz R., Masouye I., French L., Saurat J.H. Treatment of primary anetoderma with colchicines. J. Am. Acad. Dermatol. 1998; 38(6, Pt 1): 1002—3.
  5. Молочков В.А., Кочеткова Л.А., Прокофьев А.А. Анетодермия. Сборник статей научно-практической конференции «Актуальные вопросы дерматовенерологии и дерматоонкологии», 27—28 мая 2010, Москва. 2010: 17—9.
  6. Edelson R.L. Photopheresis: a clinical relevant immunobiologic response modifier. Ann. N. Y Acad. Sci. 1991; 636: 154—64.
  7. Lee K.H., Garro J. Engineering aspects of extracorporeal photochemotherapy. Yale J. Biol. Med. 1989; 62(6): 621—8.
  8. Vowels B.R., Cassin M., Boufal M.H., Walsh L.J., Rook A.H. Extracorporeal phothochemotherapy induces the production of tumor necrosis factor alpfa by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J. Invest. Dermatol. 1992; 98(5): 686—92.
  9. Zic J., Arzubiaga C., Salhany K.E., Parker R.A., Wilson D., Stricklin G.P., et al. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J. Am. Acad. Dermatol. 1992; 27(5, Pt 1): 729—36.
  10. Gerber M., Gmeinhart B., Volc-Platzer B., Kalhs P., Greinix H.T., Knobler R. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ESP). Bone Mаrrow Transplant. 1997; 19(5): 517—9.
  11. Greinix H.T., Volc-Platzer B., Rabitsch W., Gmeinhart B., Guevara-Pineda C., Kalhs P., еt al. Successful use of eхtracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998; 92(5): 3098—104.
  12. Owsianowski M., Gollnick H., Siegert W. Schwerdtfeger R., Orfanos C.E. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant. 1994; 14(5): 845—8.
  13. Knobler R., Barr M.L., Couriel D.R., Ferrara J.L., French L.E., Jaksch P., et al. Extracorporeal photopheresis: past, present, and future. J. Am. Acad. Dermatol. 2009; 61(4): 652—65.

Copyright (c) 2013 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies